Insider · CIK 0001280180

JACOBY PHILIP R JR

Reports to the SEC for 2 companies · COLUMBIA, MD

sec.gov

Transactions

Companies

Filings

CIK

0001280180

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-01-08	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)D Disposition to Issuer	Principal Accounting Officer	DDisposition to Issuer	−10K sh	$7.73	−$77.3K	44,181
2016-01-08	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)D Disposition to Issuer	Principal Accounting Officer	DDisposition to Issuer	−5,000 sh	$5.08	−$25.4K	54,181
2015-05-27	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−3,751 sh	$6.46	−$24.2K	64,041
2015-05-27	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−11.4K sh	$7.74	−$88.2K	67,792
2015-05-27	OSIRIS THERAPEUTICS, INC.S Sale	Principal Accounting Officer	SSale	−20K sh	$18.55	−$371K	12,500
2015-05-27	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−4,860 sh	$7.13	−$34.7K	59,181
2015-05-27	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+3,751 sh	$6.46	+$24.2K	27,640
2015-05-27	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+11.4K sh	$7.74	+$88.2K	23,889
2015-05-27	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+4,860 sh	$7.13	+$34.7K	32,500
2013-11-25	OSIRIS THERAPEUTICS, INC.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−3,749 sh	$6.46	−$24.2K	109,751
2013-11-25	OSIRIS THERAPEUTICS, INC.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−4,999 sh	$5.08	−$25.4K	95,128
2013-11-25	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+9,624 sh	$7.13	+$68.6K	25,873
2013-11-25	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+4,999 sh	$5.08	+$25.4K	30,872
2013-11-25	OSIRIS THERAPEUTICS, INC.S Sale	Principal Accounting Officer	SSale	−18.4K sh	$15.99	−$294K	12,500
2013-11-25	OSIRIS THERAPEUTICS, INC.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−9,624 sh	$7.13	−$68.6K	100,127
2013-11-25	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+3,749 sh	$6.46	+$24.2K	16,249
2013-02-12	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+15K sh	$7.73	+$116K	108,500
2013-02-12	OSIRIS THERAPEUTICS, INC.Non-Qualified Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+5,000 sh	$7.73	+$38.7K	113,500
2012-03-23	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+12.7K sh	$5.08	+$64.3K	98,665
2012-03-23	OSIRIS THERAPEUTICS, INC.Non-Qualified Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+7,335 sh	$5.08	+$37.3K	106,000
2011-08-15	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+2,500 sh	$0.40	+$1,000	12,500
2011-08-15	OSIRIS THERAPEUTICS, INC.Non-Qualified Stock OptionM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−2,500 sh	$0.40	−$1,000	73,500
2011-02-14	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+10.4K sh	$7.13	+$74K	66,376
2011-02-14	OSIRIS THERAPEUTICS, INC.Non-Qualified Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+9,624 sh	$7.13	+$68.6K	76,000
2010-05-28	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+1,250 sh	$0.40	+$500	10,000
2010-05-28	OSIRIS THERAPEUTICS, INC.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−1,250 sh	$0.40	−$500	56,000
2010-05-27	OSIRIS THERAPEUTICS, INC.Incentive Stock OptionA Award	Principal Accounting Officer	AAward	+7,500 sh	$6.46	+$48.5K	57,250
2010-03-12	OSIRIS THERAPEUTICS, INC.Incentive Stock OptionA Award	Principal Accounting Officer	AAward	+20K sh	$18.60	+$372K	49,750
2009-02-23	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+10K sh	$18.60	+$186K	29,750
2007-02-01	OSIRIS THERAPEUTICS, INC.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−2,000 sh	$0.40	−$800	10,500
2007-02-01	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+2,000 sh	$0.40	+$800	2,000
2004-08-09	FCNFTI CONSULTING, INCS Sale	VP and Corporate Controller	SSale	−1,000 sh	$16.22	−$16.2K	69

Recent filings

Accepted (ET)
Jan 84
OSIRIS THERAPEUTICS, INC.0001179110-16-017593
SEC(opens sec.gov)
May 294
OSIRIS THERAPEUTICS, INC.0001179110-15-008722
SEC(opens sec.gov)
Nov 264
OSIRIS THERAPEUTICS, INC.0001179110-13-017041
SEC(opens sec.gov)
Feb 134
JACOBY PHILIP R JR0001179110-13-002640
SEC(opens sec.gov)
Mar 274
JACOBY PHILIP R JR0001179110-12-005804
SEC(opens sec.gov)

Companies

Address

7015 ALBERT EINSTEIN DRIVE

COLUMBIA, MD, 21046